Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...

Pregnant women with PsA were linked to a nearly 2-fold increased risk for preterm birth compared with control pregnancies.

Genetic screening by exome sequencing identified familial hypercholesterolemia in a cohort where most FH carriers were newly diagnosed.

Lawsuits have been filed against formula manufacturer ByHeart after tests found Clostridium botulinum spores in formula samples.

A subset of patients with DISH experience rapid skeletal progression that is linked to visceral adiposity, trabecular bone deterioration, and insulin resistance.

The US Transportation Department approved the THOR-05F female crash test dummy to improve safety for women in car crashes.

Standard population-based cardiac screening tools often failed to identify younger patients at risk for a first myocardial infarction.

Women with active PsA during pregnancy were at a greater risk for preeclampsia and gestational hypertension vs population controls.

According to the 2025 March of Dimes Report Card, the United States maintained a D+ grade for maternal and infant health.

Unanticipated termination of National Institutes of Health grant funding affected 3.5% of interventional clinical trials.

A deep learning model identified an adrenal volume index from chest CT as an imaging biomarker for chronic stress and cardiovascular risk.